1. Home
  2. BLDE vs ICG Comparison

BLDE vs ICG Comparison

Compare BLDE & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLDE
  • ICG
  • Stock Information
  • Founded
  • BLDE 2014
  • ICG 2017
  • Country
  • BLDE United States
  • ICG China
  • Employees
  • BLDE N/A
  • ICG N/A
  • Industry
  • BLDE Aerospace
  • ICG Semiconductors
  • Sector
  • BLDE Consumer Discretionary
  • ICG Technology
  • Exchange
  • BLDE Nasdaq
  • ICG Nasdaq
  • Market Cap
  • BLDE 215.1M
  • ICG 230.3M
  • IPO Year
  • BLDE N/A
  • ICG 2023
  • Fundamental
  • Price
  • BLDE $2.96
  • ICG $2.44
  • Analyst Decision
  • BLDE Strong Buy
  • ICG Strong Buy
  • Analyst Count
  • BLDE 2
  • ICG 2
  • Target Price
  • BLDE $6.25
  • ICG $9.50
  • AVG Volume (30 Days)
  • BLDE 541.6K
  • ICG 24.2K
  • Earning Date
  • BLDE 05-12-2025
  • ICG 05-19-2025
  • Dividend Yield
  • BLDE N/A
  • ICG N/A
  • EPS Growth
  • BLDE N/A
  • ICG N/A
  • EPS
  • BLDE N/A
  • ICG 0.12
  • Revenue
  • BLDE $248,693,000.00
  • ICG $38,602,978.00
  • Revenue This Year
  • BLDE $5.21
  • ICG N/A
  • Revenue Next Year
  • BLDE $8.70
  • ICG $147.04
  • P/E Ratio
  • BLDE N/A
  • ICG $18.87
  • Revenue Growth
  • BLDE 10.44
  • ICG 242.68
  • 52 Week Low
  • BLDE $2.35
  • ICG $1.40
  • 52 Week High
  • BLDE $5.17
  • ICG $12.04
  • Technical
  • Relative Strength Index (RSI)
  • BLDE 58.04
  • ICG 57.03
  • Support Level
  • BLDE $2.73
  • ICG $2.01
  • Resistance Level
  • BLDE $2.99
  • ICG $2.38
  • Average True Range (ATR)
  • BLDE 0.12
  • ICG 0.22
  • MACD
  • BLDE 0.04
  • ICG 0.13
  • Stochastic Oscillator
  • BLDE 93.75
  • ICG 89.66

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments.

Share on Social Networks: